Related references
Note: Only part of the references are listed.Diagnosis and Treatment of Parkinson Disease A Review
Melissa J. Armstrong et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Differential Sensitivity of Two Endothelial Cell Lines to Hydrogen Peroxide Toxicity: Relevance for In Vitro Studies of the Blood-Brain Barrier
Olufemi Alamu et al.
CELLS (2020)
Oral Delivery of Puerarin Nanocrystals To Improve Brain Accumulation and Anti-Parkinsonian Efficacy
Sha Xiong et al.
MOLECULAR PHARMACEUTICS (2019)
Emerging therapies in Parkinson disease - repurposed drugs and new approaches
Ahmad Elkouzi et al.
NATURE REVIEWS NEUROLOGY (2019)
Parkinson's disease: Mechanisms, translational models and management strategies
Chand Raza et al.
LIFE SCIENCES (2019)
Lactoferrin Coupled Lower Generation PAMAM Dendrimers for Brain Targeted Delivery of Memantine in Aluminum-Chloride-Induced Alzheimer's Disease in Mice
Avinash Gothwal et al.
BIOCONJUGATE CHEMISTRY (2019)
Gallic acid liposomes decorated with lactoferrin: Characterization, in vitro digestion and antibacterial activity
Yating Zhang et al.
FOOD CHEMISTRY (2019)
Synthesis of sevoflurane loaded reduced graphene oxide nanoparticles system for neuroprotective effects for preconditioning against focal cerebral ischaemia
Qinjuan Wu et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2019)
Nanoparticles Mediating the Sustained Puerarin Release Facilitate Improved Brain Delivery to Treat Parkinson's Disease
Tongkai Chen et al.
ACS APPLIED MATERIALS & INTERFACES (2019)
Molecular dynamics simulations reveal the mechanism of graphene oxide nanosheet inhibition of Aβ1-42 peptide aggregation
Yibo Jin et al.
PHYSICAL CHEMISTRY CHEMICAL PHYSICS (2019)
Emerging blood-brain-barrier-crossing nanotechnology for brain cancer theranostics
Wei Tang et al.
CHEMICAL SOCIETY REVIEWS (2019)
Pharmacokinetics and drug delivery systems for puerarin, a bioactive flavone from traditional Chinese medicine
Liang Zhang
DRUG DELIVERY (2019)
Projection of the Prevalence of Parkinson's Disease in the Coming Decades: Revisited
Alexander Rossi et al.
MOVEMENT DISORDERS (2018)
Lactoferrin- and RGD-comodified, temozolomide and vincristine-coloaded nanostructured lipid carriers for gliomatosis cerebri combination therapy
Jicai Zhang et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Graphene quantum dots prevent α-synucleinopathy in Parkinson's disease
Donghoon Kim et al.
NATURE NANOTECHNOLOGY (2018)
Overcoming the Blood-Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases
Denzil Furtado et al.
ADVANCED MATERIALS (2018)
Development of a magnetic nano-graphene oxide carrier for improved glioma-targeted drug delivery and imaging: In vitro and in vivo evaluations
Sakine Shirvalilou et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2018)
Antiglioma via regulating oxidative stress and remodeling tumor-associated macrophage using lactoferrin-mediated biomimetic codelivery of simvastatin/fenretinide
Xiaopeng Mo et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Black Phosphorus Nanosheets as a Neuroprotective Nanomedicine for Neurodegenerative Disorder Therapy
Wansong Chen et al.
ADVANCED MATERIALS (2018)
Epidemiology of Parkinson's disease
Ole-Bjorn Tysnes et al.
JOURNAL OF NEURAL TRANSMISSION (2017)
Lactoferrin modified graphene oxide iron oxide nanocomposite for glioma-targeted drug delivery
Meng-Meng Song et al.
MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2017)
Uric acid demonstrates neuroprotective effect on Parkinson's disease mice through Nrf2-ARE signaling pathway
Ting-Ting Huang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Assessment of lipid peroxidation by measuring malondialdehyde (MDA) and relatives in biological samples: Analytical and biological challenges
Dimitrios Tsikas
ANALYTICAL BIOCHEMISTRY (2017)
Current and experimental treatments of Parkinson disease: A guide for neuroscientists
Wolfgang Oertel et al.
JOURNAL OF NEUROCHEMISTRY (2016)
In vitro and in vivo brain-targeting chemo-photothermal therapy using graphene oxide conjugated with transferrin for Gliomas
Haixin Dong et al.
LASERS IN MEDICAL SCIENCE (2016)
Neurotensin-Conjugated Reduced Graphene Oxide with Multi-Stage Near-Infrared-Triggered Synergic Targeted Neuron Gene Transfection In Vitro and In Vivo for Neurodegenerative Disease Therapy
Tsung-Ying Hsieh et al.
ADVANCED HEALTHCARE MATERIALS (2016)
Porous silicon-graphene oxide core-shell nanoparticles for targeted delivery of siRNA to the injured brain
Jinmyoung Joo et al.
NANOSCALE HORIZONS (2016)
Targeting Receptor-Mediated Transport for Delivery of Biologics Across the Blood-Brain Barrier
Jason M. Lajoie et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 55 (2015)
Graphene-based nanomaterials: biological and medical applications and toxicity
Fernanda M. P. Tonelli et al.
NANOMEDICINE (2015)
Fluorogenic Resveratrol-Confined Graphene Oxide For Economic and Rapid Detection Of Alzheimer's Disease
Xiao-Peng He et al.
ACS APPLIED MATERIALS & INTERFACES (2014)
Biopharmaceutics classification of puerarin and comparison of perfusion approaches in rats
Hewei Li et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2014)
PUERARIN PROTECTS DOPAMINERGIC NEURONS IN PARKINSON'S DISEASE MODELS
X. Zhang et al.
NEUROSCIENCE (2014)
Neuroprotective Effects of Puerarin on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced Parkinson's Disease Model in Mice
Guoqi Zhu et al.
PHYTOTHERAPY RESEARCH (2014)
Graphene and graphene oxide as new nanocarriers for drug delivery applications
Jingquan Liu et al.
ACTA BIOMATERIALIA (2013)
Nanoparticle accumulation and transcytosis in brain endothelial cell layers
Dong Ye et al.
NANOSCALE (2013)
Transcytosis and brain uptake of transferrin-containing nanoparticles by tuning avidity to transferrin receptor
Devin T. Wiley et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Receptor-Mediated Delivery of Magnetic Nanoparticles across the Blood-Brain Barrier
Ruirui Qiao et al.
ACS NANO (2012)
Modern methods for delivery of drugs across the blood-brain barrier
Yan Chen et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Lactoferrin-conjugated superparamagnetic iron oxide nanoparticles as a specific MRI contrast agent for detection of brain glioma in vivo
Hui Xie et al.
BIOMATERIALS (2011)
Lactoferrin conjugated PEG-PLGA nanoparticles for brain delivery: Preparation, characterization and efficacy in Parkinson's disease
Kaili Hu et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2011)
Projected Numbers of People With Movement Disorders in the Years 2030 and 2050
Jan-Philipp Bach et al.
MOVEMENT DISORDERS (2011)
Graphene and Graphene Oxide: Synthesis, Properties, and Applications
Yanwu Zhu et al.
ADVANCED MATERIALS (2010)
Puerarin Protects Dopaminergic Neurons against 6-Hydroxydopamine Neurotoxicity via Inhibiting Apoptosis and Upregulating Glial Cell Line-Derived Neurotrophic Factor in a Rat Model of Parkinson's Disease
Guoqi Zhu et al.
PLANTA MEDICA (2010)
Lactoferrin-conjugated PEG-PLA nanoparticles with improved brain delivery: In vitro and in vivo evaluations
Kaili Hu et al.
JOURNAL OF CONTROLLED RELEASE (2009)
Characterization of lactoferrin receptor in brain endothelial capillary cells and mouse brain
Rong-qin Huang et al.
JOURNAL OF BIOMEDICAL SCIENCE (2007)
Blood-brain barrier transport of therapeutics via receptor-mediation
Angela R. Jones et al.
PHARMACEUTICAL RESEARCH (2007)
Behavioral phenotyping of the MPTP mouse model of Parkinson's disease
M Sedelis et al.
BEHAVIOURAL BRAIN RESEARCH (2001)
Share Paper
